sanofi-aventis

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Patient Information Leaflet last updated on the eMC: 16/11/2011
PIL Rifadin For Infusion 600mg

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 16/11/2011 and displayed until Current
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 10/02/2011 and displayed until 16/11/2011
Reasons for adding or updating:
  • Change to manufacturer contact details
Updated on 15/11/2010 and displayed until 10/02/2011
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 31/03/2010 and displayed until 15/11/2010
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
Updated on 08/06/2009 and displayed until 31/03/2010
Reasons for adding or updating:
  • Company name change or merger
  • Change due to user-testing of patient information
Updated on 15/08/2006 and displayed until 08/06/2009
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 10/08/2006 and displayed until 15/08/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
Updated on 07/12/2000 and displayed until 10/08/2006
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   rifampicin